Skip to main content Skip to section navigation Skip to footer
Aethlon Medical, Inc. Corporate Home
  • The Hemopurifier®
    • Overview
    • The Hemopurifier® in Cancer
    • The Hemopurifier® in Infectious Disease
  • About
    • Overview
    • Leadership
    • Board of Directors
  • News & Media
    • Press Releases
    • Presentations
    • Events
    • Publications
    • Training Videos
  • Investors
    • Overview
    • Corporate News / Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
    • Analyst Coverage
  • Contact Us
Site Announcement

Aethlon Medical is closely monitoring the Bird Flu situation and stands ready to work alongside hospitals, health agencies and the FDA if existing therapies prove inadequate.

News & Media
  • Press Releases
  • Presentations
  • Events
  • Publications
  • Training Videos

Press Releases

Dec 13, 2018

Aethlon Announces Appointment of Timothy Rodell as Interim Chief Executive Officer

Nov 27, 2018

Aethlon Medical's Cancer Therapy Receives "Breakthrough Device" Designation from the U.S. Food and Drug Administration

Nov 6, 2018

Aethlon Medical Announces Second Quarter Fiscal Year 2019 Results

Nov 1, 2018

Aethlon Medical To Release Quarterly Financial Results and Host Conference Call on November 6, 2018

Oct 29, 2018

Aethlon Medical to Present at the NYC Oncology Conference

Oct 16, 2018

Aethlon Medical to Present at the 2018 BIO Investor Forum

Sep 18, 2018

Aethlon Medical Receives National Cancer Institute Award

Aug 8, 2018

Aethlon Medical Announces First Quarter Fiscal Year 2019 Results

Aug 2, 2018

Aethlon Medical To Release Financial Results for the First Quarter Fiscal Year 2019 and Host Conference Call on August 8, 2018

Jul 23, 2018

Aethlon Medical Announces Issuance of Hemopurifier® Patent To Treat Life-Threatening Viruses

  • Page 1
  • Page 2
  • Next Pagearrow_forward
rss_feed News RSS
Linkedin
Privacy Policy Disclaimer Sitemap Accessibility Statement
©2025 Aethlon Medical, Inc. All Rights Reserved.